Prucalopride (Motegrity) for Chronic Idiopathic Constipation

Date: June 3, 2019 Issue #:  1573Summary:  The FDA has approved the 5-HT4 receptor agonist prucalopride (Motegrity– Shire) for treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride is the only drug currently approved in the US for treatment of CIC that stimulates colonic peristalsis. It has been available in Europe and Canada for several years.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: amitiza Bisacodyl Constella Constipation dulcolax linaclotide Linzess lubiprostone Miralax Motegrity plecanatide Polyethylene Glycol prucalopride Resotran Restoralax Tegaserod Trulance Zelnorm Source Type: research